NCT05867251 Study of AVZO-021 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05789771 Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia. Status COMPLETED Phase N/A
NCT05774899 CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC Status RECRUITING Phase PHASE1/PHASE2
NCT05768139 First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05766410 A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC Status RECRUITING Phase PHASE2
NCT05759949 First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1
NCT05735080 Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05714072 A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis Status RECRUITING Phase PHASE1
NCT05708235 A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population Status RECRUITING Phase PHASE2
NCT05617885 Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05573126 Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05563220 Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05548127 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05524584 Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT05464173 Chidamide in Combination With Abemaciclib and Endocrinotherapy(Doctor's Choice) in Breast Cancer Patients Previously Treated With Palbociclib Status RECRUITING Phase PHASE1/PHASE2
NCT05440786 CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05386108 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05372640 Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors Status RECRUITING Phase PHASE1